Figure 2.
PARPi currently in use as anticancer agents and in phase III of clinical trials, and examples of dual PARP1–2/TNKS1–2 inhibitors in clinical studies and TNKS inhibitors in the preclinical phase.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.